Literature DB >> 15699809

Allograft bone in spinal fusion for adolescent idiopathic scoliosis.

D Raymond Knapp1, Eric T Jones, John S Blanco, Joseph C Flynn, Charles T Price.   

Abstract

OBJECTIVE: The purpose of this long-term study was to determine the efficacy of allograft bone for spinal fusion for adolescent idiopathic scoliosis. Prior studies comparing allograft and autograft have been short term.
METHODS: This multicenter retrospective study was carried out on 111 patients with 132 total curves fused for adolescent idiopathic scoliosis. Minimum follow-up was 5 years (average 72 months). A variety of segmental instrumentation was used, with most being dual-rod, multiple-hook constructs.
RESULTS: Average preoperative curve was 59 degrees with immediate correction to 29 degrees (51%) and final follow-up of 32.24 degrees (45.4%). Average loss of correction was 3.5 degrees (5.9%). There were three pseudarthroses, one infection, and no rod breakage.
CONCLUSION: Pseudarthrosis rate of 2.7% and loss of correction of 5.9% are comparable with or better than those in previous reports using autogenous bone graft and either segmental or nonsegmental instrumentation.

Entities:  

Mesh:

Year:  2005        PMID: 15699809     DOI: 10.1097/01.bsd.0000128694.21405.80

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  12 in total

Review 1.  [Bone substitutes in scoliosis surgery].

Authors:  T Lerner; H Griefingholt; U Liljenqvist
Journal:  Orthopade       Date:  2009-02       Impact factor: 1.087

2.  Deep wound infection following pediatric scoliosis surgery: incidence and analysis of risk factors.

Authors:  Sami Aleissa; David Parsons; John Grant; James Harder; Jason Howard
Journal:  Can J Surg       Date:  2011-08       Impact factor: 2.089

Review 3.  A systematic review of comparative studies on bone graft alternatives for common spine fusion procedures.

Authors:  Charla R Fischer; Ryan Cassilly; Winifred Cantor; Emmanuel Edusei; Qusai Hammouri; Thomas Errico
Journal:  Eur Spine J       Date:  2013-02-26       Impact factor: 3.134

4.  Adolescent idiopathic scoliosis correction by instrumented vertebral arthrodesis with autologous bone graft from local harvesting without bone substitute use: results with mean 3 year follow-up.

Authors:  Marco Crostelli; Osvaldo Mazza; Massimo Mariani; Dario Mascello; Carlo Iorio
Journal:  Eur Spine J       Date:  2018-04-19       Impact factor: 3.134

5.  Causes and managements of postoperative complications after degenerative scoliosis treatments with internal fixation.

Authors:  Yong-Hong Yang; Jie Zheng; Shu-Liang Lou
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 6.  Use of graft materials and biologics in spine deformity surgery: a state-of-the-art review.

Authors:  Ki-Eun Chang; Mohamed Kamal Mesregah; Zoe Fresquez; Eloise W Stanton; Zorica Buser; Jeffrey C Wang
Journal:  Spine Deform       Date:  2022-06-23

7.  Clinical and radiographic outcomes of the treatment of adolescent idiopathic scoliosis with segmental pedicle screws and combined local autograft and allograft bone for spinal fusion: a retrospective case series.

Authors:  Xiaoming Yang; Hongguang Xu; Ming Li; Suxi Gu; Xiutong Fang; Jingjie Wang; Jianqiang Ni; Dajiang Wu
Journal:  BMC Musculoskelet Disord       Date:  2010-07-14       Impact factor: 2.362

8.  Silicate-substituted calcium phosphate as a bone graft substitute in surgery for adolescent idiopathic scoliosis.

Authors:  Thomas Lerner; Ulf Liljenqvist
Journal:  Eur Spine J       Date:  2012-09-05       Impact factor: 3.134

9.  Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications.

Authors:  Kenneth Vaz; Kushagra Verma; Themistocles Protopsaltis; Frank Schwab; Baron Lonner; Thomas Errico
Journal:  SAS J       Date:  2010-09-01

Review 10.  Bone Graft Options for Spine Fusion in Adolescent Patients with Idiopathic Scoliosis.

Authors:  Xi-Ming Xu; Gong Zhang; Fei Wang; Xian-Zhao Wei; Ming Li
Journal:  Chin Med J (Engl)       Date:  2016-01-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.